Furthermore, the expression of EPG5 was correlated with longer survival of lung cancer patients and silencing EPG5 significantly promoted NSCLC cells growth, and attenuated the pro-tumor growth effect of miR-150 in vitro and in vivo. Here, EPG5 is linked to non-small cell lung carcinoma.